FLT3 inhibitors: clinical potential in acute myeloid leukemia

FLT3 inhibitors: clinical potential in acute myeloid leukemia

Marie-Anne Hospital,1–3 Alexa S Green,1–3 Thiago T Maciel,4–7 Ivan C Moura,4–7 Anskar Y Leung,8 Didier Bouscary,1–3 Jerome Tamburini1–3 1Département Développement, Reproduction, Cancer, Institut Cochin, Centre Nationa...

Full description

Bibliographic Details
Main Authors: Hospital MA, Green AS, Maciel TT, Moura IC, Leung AY, Bouscary D, Tamburini J
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:OncoTargets and Therapy
Subjects:
AML
FLT3
FLT3-ITD
tyrosine kinase
target therapy
resistance mechanisms.
Online Access:https://www.dovepress.com/flt3--inhibitors-clinical-potential-in-acute-myeloid-leukemia-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/flt3--inhibitors-clinical-potential-in-acute-myeloid-leukemia-peer-reviewed-article-OTT

Similar Items